Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

752
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
752

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative analysis of radiation therapy and surgical approaches for resectable cancers: a narrative review.

Annals of medicine and surgery (2012)·2026
Same author

AI/ML-enabled multi-omics integration of host genetics, immunity, and the gut microbiome in Crohn's disease: From diagnosis to theranostics.

SLAS technology·2026
Same author

Is <i>Fusobacterium nucleatum</i> the key mediator between oral infections and systemic diseases? Mechanistic insights and therapeutic implications.

Gut microbes·2026
Same author

Computational screening of antimicrobial peptide analogs targeting AdeB efflux transporter protein in Acinetobacter baumannii associated with multidrug resistance.

Scientific reports·2026
Same author

The role of the gut microbiome in antibiotic-driven antimicrobial resistance.

Frontiers in microbiology·2026
Same author

Copper-coated carbon nanotube surfaces for inhibiting biofilm formation by <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i>.

Cell surface (Amsterdam, Netherlands)·2026

Related Experiment Video

Updated: Apr 17, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.3K

A high-throughput cidality screen for Mycobacterium tuberculosis.

Parvinder Kaur1, Anirban Ghosh2, Ramya Vadageri Krishnamurthy3

  • 1AstraZeneca India Private Limited, Bangalore, Karnataka, India.

Plos One
|February 19, 2015
PubMed
Summary

Researchers developed a high-throughput spot-assay to find new tuberculosis drugs. This automated method reduces bio-hazard risks in BSL-3 labs, aiding the discovery of novel mycobactericidal compounds.

More Related Videos

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

8.3K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.4K

Related Experiment Videos

Last Updated: Apr 17, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.3K
A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

8.3K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.4K

Area of Science:

  • Microbiology
  • Drug Discovery
  • Bio-safety Engineering

Background:

  • Mycobacterium tuberculosis (Mtb) aerosol exposure poses significant risks to researchers in BSL-3 facilities.
  • Automation and high-throughput screening (HTS) are crucial for minimizing manual procedures and advancing TB research.

Purpose of the Study:

  • To develop and validate a high-throughput, 24-well spot-assay for selecting bactericidal compounds against Mtb.
  • To assess the assay's utility in identifying novel drug targets and compounds for TB treatment.

Main Methods:

  • Validated the spot-assay concept using Mycobacterium smegmatis (Msm) as a surrogate, then confirmed with Mtb and reference drugs (RIOE).
  • Screened Mtb using the spot-assay against a large compound library, comparing results with conventional gold standard methods (correlation, r2 = 0.808).
  • Utilized an automated spot-assay for Minimum Bactericidal Concentration 90 (MBC90) determination on resistant and sensitive Mtb clinical isolates and in kinetic screens.

Main Results:

  • The spot-assay demonstrated strong correlation (r2 = 0.808) with conventional methods for selecting bactericidal compounds.
  • Automated spot-assay enabled efficient MBC90 determination for various Mtb isolates.
  • The assay successfully detected Mtb cidality in kinetic screens following genetic or chemical inhibition.

Conclusions:

  • The developed spot-assay is a simple, economical, and quantitative HTS method for TB drug discovery.
  • This HTS approach significantly minimizes bio-hazard risks associated with Mtb research.
  • The spot-assay facilitates the selection of novel Mtb targets and mycobactericidal compounds, impacting TB drug discovery.